Sándor Németh is a partner at Szecskay Attorneys at Law who focuses on Life-sciences with an emphasis on Biotech, corporate M&A transactions, and, his signature area of expertise, wealth management and trusts.
Sándor has solid experience in private clientele, including succession planning, wealth management and family businesses, which is an area in growing demand on the legal market place.
As the Chair of the Legal Committee of the Hungarian Biotechnology Association, Sándor is certainly the name to go to for Start-ups and innovative SMEs in the Life-sciences sector. Within this field, Sándor has a particular interest in R&D, with a specific emphasis on clinical trials.
He is a lecturer on International Corporate Law at Pázmány Péter University.
He is fluent in English and German and conversational in Russian.
"The team has a very high standard, is hand-on, knowledgeable and very good at time management, vey approachable and responsive."
Legal500 2021, Commercial, Corporate and M&A
One client describes Sándor Németh as "very pragmatic and knowledgeable," and adds that "he is one of the leading lawyers in this field."
Chambers Europe, 2020, Life Sciences
"It is one of the leading independent firms with an international outlook," adding: "The lawyers have good linguistic capacity, business diligence and a pragmatic approach; they totally match our expectation."
Chambers Europe, 2020, Life Sciences Department
“On time, flexible, responsive and adaptive to changes in course; good understanding of the core issues and problems; focused work. Excellent customer relations and very good attitude towards client. No weaknesses so far.”
IFLR1000, 2020, Financial and Corporate
Sources describe his style as "always available and proactive", adding that he "quickly gives advice in the clearest possible terms". Interviewees also remark that he is "reliable, knowledgeable and pragmatic."
Chambers Europe, 2019, Life Sciences Department
"He tells us the details of the case but doesn't take unnecessary extra time and explains everything in an understandable way."
Chambers Europe, 2017, Life Sciences
Other professional memberships: